Byrna Technologies' price target soars to $86 with innovative marketing, robust financials, and new product launches. Click ...

"TGFB2 has emerged as a master regulator of immune suppression, not just in cancer but across multiple chronic diseases,” said Dr. Trieu. "Our work on OT-101 aims to neutralize TGFB2-driven resistance ...

The small-molecule discovery could help in overcoming cell culture bottlenecks such as rapid degradation and high production costs.

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Alcoa's vertical integration, aluminum demand, resilience to tariffs, and potential upside make it an attractive investment ...

Our particular market focuses on those people who are interested in eating healthy foods to get access to high-quality ...

Europe faces a well-known productivity malaise, with a large and widening aggregate productivity gap relative to the U.S. In this paper, we provide a novel diagnosis of the firm-level roots of ...

Insulin-like growth factor (IGF) 1 is a member of a family ... IGF1 is a major gene target of growth hormone and its product mediates many of the actions of growth hormone on growth and ...

You should consider the SPDR Russell 1000 Yield Focus ETF (ONEY), a passively managed exchange traded fund launched on 12/02/2015. The fund is sponsored by State Street Global Advisors. It has amassed ...

South Korea’s top economic think tank on Tuesday slashed its growth forecast for the country’s economy for the second time in ...